1-6 of 6
Denice Tsao-Wei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Follow-up and T Cell Characteristics of Patients with ASXL1 -Mutated Relapsed or Refractory MDS or CMML Treated with Guadecitabine and Atezolizumab

Casey L. O'Connell, Maria R. Baer, Vu H. Duong, Andreas Due Ørskov, Jakob Werner Hansen, Sunil Kumar Saini, Denice Tsao-Wei, Justin Cheng, Peter A. Jones, Kirsten Grønbæk
Journal: Blood
Blood (2023) 142 (Supplement 1): 1883.
https://doi.org/10.1182/blood-2023-189486
Published: 2023
Journal Articles

Prevalence and Prognostic Significance of CD5 Immunohistochemistry in De-Novo DLBCL in a Western Population Cohort

Ajaz Bulbul, MBBS, MD, Kyaw Zin Thein, MDMBBS, Emilio Paul Araujo-Mino, MD, Sai-Ching J Yeung, MD PhD FACP, Denice Tsao-Wei, Matney Huber, Siham Chouial, Sanjay Awasthi, Masoud Khorsand
Journal: Blood
Blood (2017) 130 (Supplement 1): 5218.
https://doi.org/10.1182/blood.V130.Suppl_1.5218.5218
Published: 2017
Journal Articles

a Phase I California Cancer Consortium Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory CD20+ B-Cell Lymphoma; Efficacy, Safety and Immune Correlative Analysis

Joseph Tuscano, MD, Susan Groshen, PhD, Denice Tsao-Wei, Emanual Maverakis, MD, Paul R. Kaesberg, MD, Tanya Siddiqi, MD, Leslie Popplewell**, MD, Sikander Ailawadhi, Myo Htut, Robert W. Chen, MD, Mark Kirschbaum, MD, Mark T. Schroeder, MD, Brian A Jonas, MD PhD, Ted Wun, MD FACP, FRCPA, Neil Palmisiano, MD, David F. Claxton, Edward Newman, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4086.
https://doi.org/10.1182/blood.V130.Suppl_1.4086.4086
Published: 2017
Journal Articles

Oncolytic Reovirus Immune Priming: A Phase 1b Study of Reolysin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Kevin R. Kelly, MD PhD, Kaijin Wu, PhD, Denice Tsao-Wei, Susan Groshen, Timothy Junius Triche, Jr., PhD, Ann Mohrbacher, Grace Chang, MD, Donna Fernando, Imran N Siddiqi, MD PhD, Matt Coffey, George Gill, Amy Lee, Jennifer S. Carew, PhD, Steffan T. Nawrocki, PhD
Journal: Blood
Blood (2016) 128 (22): 4507.
https://doi.org/10.1182/blood.V128.22.4507.4507
Published: 2016
Journal Articles

Pattern of Care and Association of Response with Rituxan Among Primary and Secondary Immune Thrombocytopenia Patients

Ajaz Bulbul, MBBS, MD, Sadaf Rashad, Denice Tsao-Wei, Susan Groshen, Matney Huber, Ilene Ceil Weitz, MD
Journal: Blood
Blood (2016) 128 (22): 4920.
https://doi.org/10.1182/blood.V128.22.4920.4920
Published: 2016
Journal Articles

Efficacy and Safety of Combined Rituximab and Ipilimumab to Treat Patients with Relapsed/Refractory CD20+ B-Cell Lymphoma

Barbara Marie Galligan, MD, Denice Tsao-Wei, Susan Groshen, Mark Kirschabum, Robert O'Donnell, Paul R. Kaesberg, MD, Tanya Siddiqui, Leslie Popplewell, Ailawadhi Sikander, Htut Myo, Robert Chen, John F. DiPersio, MD PhD, Neil D. Palmisiano, MD, David F. Claxton, MD, Edward M. Newman, PhD, Joseph Tuscano, MD
Journal: Blood
Blood (2015) 126 (23): 3977.
https://doi.org/10.1182/blood.V126.23.3977.3977
Published: 2015